First Header Logo Second Header Logo

Connection

Steven Park to Lymphoma, T-Cell

Back to Details
This is a "connection" page, showing publications Steven Park has written about Lymphoma, T-Cell.
Steven Park
Connection Strength
0.696
Lymphoma, T-Cell
  1. Moore DC, Elmes JB, Shibu PA, Larck C, Park SI. Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas. Ann Pharmacother. 2020 Apr; 54(4):371-379.
    View in: PubMed
    Score: 0.696
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.